Total planned funding: $259,506,390
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $120,701,839 |
Uganda | $35,928,171 |
Nigeria | $21,786,050 |
Côte d'Ivoire | $15,636,170 |
Ethiopia | $13,373,950 |
Zambia | $13,355,000 |
Zimbabwe | $10,480,002 |
Dominican Republic | $5,018,676 |
Vietnam | $4,444,565 |
Guyana | $2,973,899 |
Rwanda | $2,700,000 |
Namibia | $2,526,684 |
Cameroon | $2,106,303 |
Haiti | $2,024,443 |
Botswana | $1,827,827 |
Mozambique | $1,670,000 |
Indonesia | $800,000 |
Tanzania | $751,500 |
Ukraine | $500,000 |
South Sudan | $330,000 |
Cambodia | $173,311 |
Malawi | $150,000 |
Angola | $150,000 |
Eswatini | $50,000 |
Lesotho | $40,000 |
Asia Regional Program | $8,000 |
Ghana | $0 |
Kenya | $0 |
Caribbean Region | $0 |
Organizational Types
Implementing Agency | $259,506,390 |
Program Areas
Treatment | $65,451,979 |
Care | $57,880,064 |
Prevention | $47,699,833 |
Governance and Systems | $26,427,696 |
Testing | $11,388,524 |
Budget Codes
HTXS: Treatment: Adult Treatment | $58,087,536 |
HBHC: Care: Adult Care and Support | $21,097,353 |
HKID: Care: Orphans and Vulnerable Children | $20,166,493 |
HVTB: Care: TB/HIV | $14,839,608 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,140,615 |
HVOP: Sexual Prevention: Other Sexual Prevention | $12,650,812 |
HVCT: Testing: HIV Testing and Counseling | $11,388,524 |
HVSI: Strategic Information | $10,275,441 |
OHSS: Health Systems Strengthening | $8,596,280 |
HMBL: Biomedical Prevention: Blood Safety | $8,154,778 |
HLAB: Laboratory Infrastructure | $7,555,975 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,955,138 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $5,621,043 |
PDTX: Treatment: Pediatric Treatment | $3,964,443 |
HTXD: Treatment: ARV Drugs | $3,400,000 |
PDCS: Care: Pediatric Care and Support | $1,776,610 |
HMIN: Biomedical Prevention: Injection Safety | $121,447 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $56,000 |
Top Partner Programs
University of the Witwatersrand:
$67,558,812
View countries
TB/HIV Care Association:
$14,388,141
View countries